Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy

by M R Konorev
Published 2012-12-01

Risk Evaluation for the Formation of Gastroduodenal Erosion and Ulceration Induced by Meloxicam in Patients with Seropositive and Seronegative Rheumatoid Arthritis

by R. A. Pavlyukov, M. R. Konorev
Published 2019-05-01

Use of probiotics and probiotic-based immunomodulators as adjuvant therapy for Helicobacter pylori eradication

by M R Konorev, T M Andronova, M E Matveenko
Published 2016-12-01

Advisable including glucosaminylmuramyldipeptide in Helicobacter pylori therapy: experience of ten-year investigation

by M. R Konorev, S. V Guryanova, E. N Tyshevich, R. A Pavlyukov, O. Yu Borisova
Published 2020-12-01